| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |